London, April 2:

GlaxoSmithKline (GSK), Britain’s largest drug company, has signed an outsourcing deal with India’s Tata Consulting Services to establish a drug development support facility in Mumbai.

A company statement stated that under the terms of the deal, TCS will support GSK’s global clinical research and development programme by providing outsourced data management and medical trial reporting services. The arrangement will create nearly 100 new jobs on an existing site and reports say that the deal is understood to be worth more than £10 million.

GSK already has sizeable research operations in Mumbai and Bangalore and employs 2,400 people in India, where it controls 5.9 per cent of the pharmaceuticals market, The Times reported.

Amber Salzman, senior vice-president of development operations at GSK, said in a statement that the company had picked TCS as a partner because of its strong record in knowledge process outsourcing and operational excellence.